INTERVIEW: Why Microsaic Systems are now competing on a world stage

Microsaic Systems plc (LON: MSYS) CEO Glenn Tracey talks to DirectorsTalk about its Final Results for the year ended 31st Dec 2018. Glenn talks us through the achievements against what he’d set out to do, explains what’s difference from a couple of years ago, if a small foot-print means less performance, competing on a world stage and 2019 so far and what we can expect.

Microsaic Systems plc is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry (“MS”) instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company works with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.

The company’s compact MiD® MS systems retain the functionality of larger conventional MS systems, while being easier to use by non-specialists, and consume less energy and have lower running costs.

Share this interview

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on whatsapp
WhatsApp
Microsaic Systems plc
INTERVIEW: Why Microsaic Systems are now competing on a world stage

Other Interviews

More News

Ask your questions

Do you have questions you’d like to ask this company, get in touch and we’ll ask them for you.   

I have questions